低对比剂剂量双能CT细胞外容积分数定量心肌局灶性瘢痕的可行性
前瞻性纳入33例陈旧性心肌梗死患者,比较低对比剂剂量双能CT延迟碘增强细胞外容积分数(DECT-LIE-ECV)与心脏磁共振(CMR)ECV对心肌局灶性瘢痕(MFS)的定量效能。节段水平DECT诊断准确度较低(AUC 0.711 vs 0.892),但病灶水平两者准确度接近完美(AUC 0.989 vs 0.985),提示直接靶向瘢痕区域时低对比剂DECT-ECV可准确量化MFS。
要点
- 低对比剂DECT-LIE-ECV在直接测量瘢痕区域时与CMR-ECV高度相关(r=0.76)且诊断准确度接近完美。
- 节段水平DECT-ECV与CMR-ECV仅弱相关(r=0.21),诊断准确度低于CMR。
- 该方法为CMR禁忌患者提供了无创定量心肌瘢痕的补充工具。
关键影像表现/征象
- MFS阳性节段ECV高于阴性节段:CMR为41% vs 29%,DECT为33% vs 25%。
- 病灶水平MFS区域ECV高于远端心肌:CMR为57% vs 27%,DECT为48% vs 25%。
- DECT-LIE-ECV与CMR-ECV在节段水平弱相关(r=0.21,P<.001),平均偏差0.8%。
- DECT-LIE-ECV与CMR-ECV在病灶水平强相关(r=0.76,P<.001),平均偏差0.8%。
诊断标准与关键数值
- 节段水平诊断MFS的AUC:DECT为0.711,CMR为0.892,差异有统计学意义(P<.001)。
- 病灶水平诊断MFS的AUC:DECT为0.989,CMR为0.985,差异无统计学意义(P=.720)。
临床应用与阅片要点
- 阅片时应直接针对可疑瘢痕区域测量DECT-LIE-ECV,而非依赖全节段水平分析,以发挥其高准确度。
- DECT-ECV在节段水平与CMR一致性较弱,不宜单独用于逐节段筛查或排除MFS。
- 对于CMR禁忌的陈旧性心肌梗死患者,可考虑低对比剂DECT-LIE-ECV作为补充定量手段。
局限性
- 单中心前瞻性研究,最终分析样本量较小(28例患者)。
- 仅纳入陈旧性心肌梗死患者,结论外推至其他心肌病变需谨慎。
- 节段水平DECT与CMR相关性弱,提示方法学一致性受测量区域影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the quantitative efficacy of low-contrast-agent-dose dual-energy CT (DECT) myocardial extracellular volume (ECV) for myocardial focal scar (MFS).
METHODS: 33 patients with confirmed old myocardial infarction (OMI) were prospectively enrolled. All underwent DECT late iodine enhancement (LIE), cardiac magnetic resonance (CMR) late gadolinium enhancement (LGE), native and enhanced T1 mapping. DECT-LIE-ECV and CMR-ECV were measured in 1-16 myocardial segments of the left ventricle. Additionally, with reference to the CMR-LGE images, DECT-LIE-ECV and CMR-ECV of the MFS and the remote myocardium at a same slice were measured. Quantitative performance was assessed via Spearman correlation, Bland-Altman analysis, ROC curves, and DeLong's tests.
RESULTS: A total of 438 myocardial segments from 28 patients were analyzed (including 101 MFS-positive, 337 MFS-negative). (2) MFS-positive segments showed higher ECV than MFS-negative (CMR: 41% vs 29%; DECT: 33% vs 25%). DECT-LIE-ECV correlated weakly with CMR-ECV (r = 0.21, P < .001) but had moderate agreement (mean bias: 0.8%). Diagnostic accuracy was lower for DECT (AUC: 0.711) than CMR (AUC: 0.892; P < .001). (3) Lesion-level: MFS regions had higher ECV than remote myocardium (CMR: 57% vs 27%; DECT: 48% vs 25%). DECT-LIE-ECV correlated strongly with CMR-ECV (r = 0.76, P < .001) and showed moderate agreement (mean bias: 0.8%). Both methods had near-perfect diagnostic accuracy (DECT AUC: 0.989; CMR AUC: 0.985; P = .720).
CONCLUSION: Low-contrast DECT-LIE-ECV accurately quantifies MFS when targeting scar regions directly, offering a promising supplementary tool for myocardial scar quantification, especially for patients with contraindications to CMR.
ADVANCES IN KNOWLEDGE: The key finding of this study is the validation that low-contrast DECT-LIE-ECV enables accurate quantitative assessment of MFS via direct scar region targeting, providing a novel non-invasive supplementary to the reference standard CMR. This finding expands the clinical application of low-contrast DECT-LIE in cardiovascular imaging and supplements the evidence base for non-CMR-based ECV quantification in MFS assessment.
引用
- Chen F, Jia T, Luo L, et al. The feasibility of low contrast dose dual-energy CT for quantifying myocardial focal scar via extracellular volume fraction. Br J Radiol. 2026. PMID: 42275178. doi:10.1093/bjr/tqag146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。